A second Zantac cancer trial ends with hung jury | Reuters
WEB5 days ago · The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree on whether Boehringer ...
GSK settles two California lawsuits related to heartburn drug Zantac
WEB5 days ago · Sept 18 (Reuters) - British drugmaker GSK (GSK.L) said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does ...
Boehringer Ingelheim Faces Second Hung Jury in Chicago Zantac …
WEB5 days ago · By Brendan Pierson. (Reuters) -The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree ...
Zantac Lawsuit: Status, Eligibility, & Settlements - Drugwatch
WEBSep 3, 2024 · People who took Zantac made with ranitidine and developed cancer filed lawsuits after manufacturers issued ranitidine and Zantac recalls for the potential risk of cancer. FDA found Zantac’s active ingredient ranitidine contained N-Nitrosodimethylamine (‘NDMA’) — a probable human carcinogen.
Delaware top court will hear drugmakers' appeal to end Zantac …
WEBAug 27, 2024 · Delaware's highest court said on Tuesday it will hear an appeal by GSK and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.
GSK shares tumble after Delaware court ruling on Zantac - Financial Times
WEBJun 3, 2024 · GSK shares dropped almost 10 per cent on Monday after a ruling from a Delaware judge left the UK drugmaker exposed to US jury trials over its allegedly carcinogenic heartburn treatment Zantac.
GSK set to face jury trials over heartburn drug Zantac - Financial Times
WEBJun 1, 2024 · The ruling by Judge Vivian Medinilla means that scientific experts will be able to testify before a jury that there is a link between the plaintiffs’ cancers and their exposure to NDMA, a probable...
Victory for drugmakers GSK and Boehringer in $640 million Zantac …
WEBMay 24, 2024 · Drugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s claim that the blockbuster heartburn drug Zantac caused her cancer, handing the companies a win in ...
Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts
WEBApr 5, 2024 · Sanofi has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday.
Boehringer, GSK, Pfizer Still Face Zantac Cases Despite Mistrial
WEB4 days ago · Zantac manufacturers still face federal, state cases. An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but won’t be the last. Illinois resident Ronald Kimbrow in 2023 sued Boehringer Ingelheim Pharmaceuticals Inc., GlaxoSmithKline Holdings, Pfizer Inc., Walgreens Boots ...
Skip to content